| abstract |
The invention comprises (a) canagliflozin and (b) one or more ACE inhibitors or one or more ARBs or one or more PPARĪ³ agonists. A method of treating, delaying, slowing the progression and / or preventing a disorder comprising administering to a subject in need thereof a therapeutically effective amount of a combination therapeutic agent consisting of or consisting essentially of, and A method for treating, delaying, slowing and / or preventing fatty liver disorders (eg, NASH or NAFLD) comprising administering to a subject in need thereof a therapeutically effective amount of canagliflozin Objective. |